Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals, Inc. (AIDA) Revenue
Annual & quarterly revenue history · segment & region breakdown
AIDA · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAida Pharmaceuticals, Inc. trailing twelve-month (TTM) revenue is $0.04B, a decrease of 1.48% year-over-year from $0.03B in FY2007.
Revenue trend
2007 – 2004 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2007-12-31 | $0.03B | -$0.00B | -1.48% |
| 2006-12-31 | $0.03B | +$0.01B | +20.86% |
| 2005-12-31 | $0.02B | +$0.01B | +56.77% |
| 2004-12-31 | $0.02B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Aida Pharmaceuticals, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Aida Pharmaceuticals, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Aida Pharmaceuticals, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AIDA revenue · 4 questionsAIDA's trailing twelve-month (TTM) revenue is $0.04B. That is a decrease of 1.48% year-over-year from $0.03B in FY2007.
▸ Source: FMP · Aida Pharmaceuticals, Inc. SEC filings · GAAP · Aida Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026